NCT06518252 Risk of Sudden Cardiac Death in UN Athletes
| NCT ID | NCT06518252 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universidad Nacional de Colombia |
| Condition | Death, Sudden, Cardiac |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2023-11-24 |
| Primary Completion | 2024-12-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2023-11-24 with a primary completion date of 2024-12-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The detection of sudden cardiac death risk in athletes is a topic of great relevance in the field of sports physiotherapy and physical activity. High-performance sports practice involves anatomical and physiological changes that can modify the mechanical and electrical properties of the heart, increasing the risk of potentially fatal cardiac events. Therefore, it is essential to implement early detection strategies to identify at-risk athletes and prevent tragedies during sports practice. Methodology: This study focuses on the prevalence of sudden cardiac death risk, using a 12-lead electrocardiogram as the primary detection tool. This examination will allow for the evaluation of the heart's electrical activity and the detection of potential anomalies that could predispose athletes to adverse cardiac events during sports practice. In addition to the electrocardiogram, cardiovascular screening questionnaires will be administered to collect information on personal and family health histories, as well as other relevant risk factors. In conjunction with the project's researchers, the sports medical team of the Universidad Nacional de Colombia will be responsible for conducting the evaluations, ensuring the precision and reliability of the obtained results. A detailed analysis of the collected data will be performed using statistical tools to identify possible correlations between the evaluated risk factors and the presence of sudden cardiac death risk in athletes. Logistic regression models will be employed to determine the strength of association between the studied variables and cardiovascular risk in this specific population. Expected Results: It is anticipated that implementing pre-participation evaluations, including the electrocardiogram and cardiovascular screening questionnaires, will enable the identification of athletes at higher risk of sudden cardiac death. These results will allow for the establishment of individualized risk profiles and the design of personalized prevention strategies for each athlete. Additionally, it is expected that the findings of this study will contribute to the development of early detection protocols for sudden cardiac death risk in athletes, which can be effectively implemented in sports settings. The information generated from this study will provide a solid foundation for clinical decision-making and the implementation of preventive measures to benefit the health and well-being of high-performance athletes.
Eligibility Criteria
Inclusion Criteria: * Athletes belonging to the sports teams of the National University of Colombia, Bogotá campus. * Subject's sports history (practice time exceeding 2 years). * Individuals aged 18 to 35 years, without discrimination based on biological sex. * Training time exceeding 6 hours per week in their sports modality (weekly training record). * Personal history of cardiovascular disease (cardiac malformations or previously detected sudden death risk). * Athletes who attend at least 90% of the training sessions planned by the coach. Exclusion Criteria: * Personal history of metabolic (type 1 and 2 diabetes mellitus), neurological (spinal cord injury), or renal disease. * Routine consumption of alcohol or psychoactive substances. * Use of antihypertensive medications, beta-blockers, or inotropes. * Cardiovascular disease diagnosed with previously established pharmacological management.
Contact & Investigator
Wilder Villamil-Parra, PhD.Sciences
STUDY DIRECTOR
Universidad Nacional de Colombia
Frequently Asked Questions
Who can join the NCT06518252 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Death, Sudden, Cardiac. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06518252 currently recruiting?
Yes, NCT06518252 is actively recruiting participants. Contact the research team at jumurilloc@unal.edu.co for enrollment information.
Where is the NCT06518252 trial being conducted?
This trial is being conducted at Bogotá, Colombia.
Who is sponsoring the NCT06518252 clinical trial?
NCT06518252 is sponsored by Universidad Nacional de Colombia. The principal investigator is Wilder Villamil-Parra, PhD.Sciences at Universidad Nacional de Colombia. The trial plans to enroll 250 participants.